Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Review ArticleReview Article

Imidazoline Receptor System: The Past, the Present, and the Future

Pascal Bousquet, Alan Hudson, Jesús A. García-Sevilla and Jun-Xu Li
Charles P. France, ASSOCIATE EDITOR
Pharmacological Reviews January 2020, 72 (1) 50-79; DOI: https://doi.org/10.1124/pr.118.016311
Pascal Bousquet
Faculty of Medicine, University of Strasbourg, Strasbourg, France (P.B.); Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada (A.H.); Laboratory of Neuropharmacology, University Research Institute on Health Sciences, University of the Balearic Islands, Palma de Malllorca, Spain (J.A.G.-S.); and Department of Pharmacology and Toxicology, University at Buffalo, Buffalo, New York (J.-X.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Hudson
Faculty of Medicine, University of Strasbourg, Strasbourg, France (P.B.); Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada (A.H.); Laboratory of Neuropharmacology, University Research Institute on Health Sciences, University of the Balearic Islands, Palma de Malllorca, Spain (J.A.G.-S.); and Department of Pharmacology and Toxicology, University at Buffalo, Buffalo, New York (J.-X.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesús A. García-Sevilla
Faculty of Medicine, University of Strasbourg, Strasbourg, France (P.B.); Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada (A.H.); Laboratory of Neuropharmacology, University Research Institute on Health Sciences, University of the Balearic Islands, Palma de Malllorca, Spain (J.A.G.-S.); and Department of Pharmacology and Toxicology, University at Buffalo, Buffalo, New York (J.-X.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun-Xu Li
Faculty of Medicine, University of Strasbourg, Strasbourg, France (P.B.); Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada (A.H.); Laboratory of Neuropharmacology, University Research Institute on Health Sciences, University of the Balearic Islands, Palma de Malllorca, Spain (J.A.G.-S.); and Department of Pharmacology and Toxicology, University at Buffalo, Buffalo, New York (J.-X.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles P. France
Roles: ASSOCIATE EDITOR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Chemical structure of clonidine.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Chemical structures of candidate endogenous imidazoline receptor ligands harmane, IAA-RP, harmalan, and agmatine.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Chemical structures of aminopyrrolines of interest LNP911, LNP906, LNP509, and LNP599.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Chemical structures of I2 receptor ligands 2-BFI, BU224, tracizoline, CR4056, phenyzoline, and idazoxan.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    PET imaging of I2 receptors in healthy volunteers treated with the radioligand 11C-BU99008. Data adapted from Tyacke et al. (2018) with permission.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Two mechanisms underlying imidazoline I2 receptor agonist-induced analgesia. I2 receptor agonists can increase the synaptic monoamine (5-HT and norepinephrine) level via MAO inhibition, which can subsequently activate the individual monoaminergic receptors. I2 receptor agonists can also inhibit central glial activity, attenuate the secretion of proinflammatory cytokines, and then attenuate the neural activity of the second-order pain-projecting pathways. 5-HT, serotonin; AR, adrenergic receptor; I2R, I2 receptor.

Tables

  • Figures
    • View popup
    TABLE 1

    Summary of the pharmacological effects mediated by imidazoline receptors

    Receptor TypeCommon LigandsPharmacological Effects
    Cellular EffectCellular ActionIn Vivo EffectIn Vivo Action
    I1LNP509, LNP599, LNP91, LNP911Cell viabilityIs antiproliferative; protects cell viabilityBlood pressureReduces blood pressure and heart rate
    Insulin and adiponectinStimulates the secretion of adiponectin; increases insulin sensitivity; is insulinotropicHeart arrhythmiaHas an antiarrhythmic effect
    NeuronsIncreases MAPK activity; decreases GABAA receptor–mediated inhibitory postsynaptic currentsHeart failureImproves cardiac performance in congestive heart failure; prevents ventral hypertrophy
    Glucose and lipid metabolismReduces insulin resistance, hyperinsulinemia, hypertension, and metabolic syndrome
    I22-BFI, BU224, CR4056, tracizoline, idazoxan, phenyzolinePainIs antinociceptive in multiple models of chronic pain; enhances the antinociceptive effects of opioids; reduces antinociceptive tolerance and physical dependence of opioids
    Subjective effectsProduces characteristic discriminative stimulus effects specific to I2 receptor activation
    NeuroprotectionIs neuroprotective in a rat cerebral ischemia model
    Body temperatureReduces body temperature and may involve temperature regulation
    I3KU-14RInsulin secretionFacilitates insulin secretion
PreviousNext
Back to top

In this issue

Pharmacological Reviews: 72 (1)
Pharmacological Reviews
Vol. 72, Issue 1
1 Jan 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Imidazoline Receptor System: The Past, the Present, and the Future
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Review ArticleReview Article

A Review of Imidazoline Receptors

Pascal Bousquet, Alan Hudson, Jesús A. García-Sevilla and Jun-Xu Li
Pharmacological Reviews January 1, 2020, 72 (1) 50-79; DOI: https://doi.org/10.1124/pr.118.016311

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Review ArticleReview Article

A Review of Imidazoline Receptors

Pascal Bousquet, Alan Hudson, Jesús A. García-Sevilla and Jun-Xu Li
Pharmacological Reviews January 1, 2020, 72 (1) 50-79; DOI: https://doi.org/10.1124/pr.118.016311
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • I. Introduction
    • II. History of Imidazoline Receptors
    • III. Endogenous Imidazoline Receptor Ligands
    • IV. Imidazoline Subtype 1 Receptors
    • V. Imidazoline Subtype 2 Receptors
    • VI. Imidazoline Subtype 3 Receptors
    • VII. Summary and Conclusions
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Sex-Based Pharmacology
  • Pharmacology of Polymyxins
  • Ontogeny of Hepatic Transport and Drug Metabolism
Show more Review Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics